Abstract:Aim: To construct a vector expressing through target gene given by human telomerase reserve transcriptase (hTERT) promoter with pLHCX as vector and realize target expression. Methods: Experiments were performed at the Key Laboratory of Molecular Medicine from September 2005 to May 2006. 1 The phTERT-luc plasmid containing 319 bp hTERT core promoter was presented by Dr. Zheng from Military Academy of Science; Retrovirus vector pLHCX was presented by Professor Zhu from Zhejiang University; The plasmid pCMV-Neo-BamH-wtp53 containing 1.8 kb wtp53 gene was presented by Professor Zhu from Second Military Medical University of Chinese PLA; Enhanced green fluorescent protein report plasmid pEGFP-N2 and pEGFP-C1 were kept in this laboratory; human carcinoma of large intestine cell strain SW620 and HT-29, human cervical carcinoma cell strain Hela, human lung carcinoma cell strain A549, and human lung embryo fibroblast MRC-5 were kept in this laboratory. 2 The plasmid pLHCX-hTERT-EGFP expressing EGFP driven by hTERT promoter and the plasmid pLHCX-hTERT-wtp53 expressing wtp53 also driven by hTERT promoter were constructed through directional cloning. The plasmid pLHCX-hTERT-EGFP and the plasmid pLHCX-CMV-EGFP were used for the transfection of human carcinoma of large intestine cell strain SW620 and HT-29, human cervical carcinoma cell strain Hela, human lung carcinoma cell strain A549, and human lung embryo fibroblast MRC-5. 3 The flow cytometer was used to analyze the transfection efficiency of pLHCX-hTERT-EGFP so as to declare the HTERT promoter specific expression in tumor cells. The human colon cancer cell line SW620, which the p53 gene is mutation, were infected with the plasmid pLHCX-hTERT-wtp53 and p53 mRNA, p53 protein were demonstrated with RT-PCR and Western blot. The normal human embryo lung fibroblast cell strain MRC-5 and the human colon cancer cell line SW620 and HT-29 were treated with the plasmid pLHCX-hTERT-wtps3, the propagate inhibition and apoptosis of cells were detected by MTT' and FCM, respectively. Results: 1 The plasmids pLHCX-hTERT-EGFP and pLHCX-hTERT-wtp53 were successfully constructed, which were confirmed by restriction endonuclease and sequencing. Green fluorescent protein expression was observed by pLHCX-hTERT-EGFP transfection SW620. The sequencing verified that complete wtp53 fragment was found. 2 Flow cytometry declared that enhanced green fluorescent protein expression was significantly higher in the SW620, Hela and A549 than the MRC-5 after pLHCX-hTERT-EGFP treatment (P < 0.05), but no significant difference was found in positive and negative cells above mentioned (P > 0.05). 3 The expression of wtp53 mRNA and the protein were demonstrated by RT-PCR and Western blot, respectively. 4 MTT showed that recombinant plasmid had significant inhibition on carcinoma of large intestine with positive telomerase, but had no significant effects on MRC-5 cells with negative telomerase (P < 0.05). 5 Flow cytometry showed that the apoptosis of carcinoma of large intestine with positive telomerase was significantly higher than the MRC-5 cells with negative telomerase induced by recombinant plasmid (P < 0.05). Conclusion: The retroviral vector pLHCX-hTERT-EGFP can express in tumor cells specifically and the retroviral vector pLHCX-hTERT-wtp53 can affect carcinoma of large intestine with positive telomerase specifically.

Construction of lentiviral expression vector with telomerase reverse transcriptase and green fluorescent protein recombinant gene

Immortalization of Human Umbilical Vein Endothelial Cells by Transfected with Htert and SV40LT

Construction of Retroviral Vector Containing Enhanced Green Fluorescent Protein Gene Driven by Human Telomerase Reserve Transcriptase Gene Promoter and Expression in Human Cervical Cancer Hela Cell

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Construction of Recombinant Lentivirus Vector Carrying hTERT Gene and Its Packaging and Expression

Construction and identification of eukaryotic expression plasmid carrying hTERT-P2A-EGFP

Construction and Expression of Retroviral Vector Phtertgplox for Reversible Immortalization

Construction of Two Different Recombinant Plasmids Containing Human Telomerase Reverse Transcriptase Gene Promoter

Construction and Packaging of a Recombination Adenovirus Expressing Human Telomerase Reverse Transcriptase(htert) Gene

Construction of Expression Vector of Htert- Hil18 Fusion Gene and Induction of Cytotoxic T Lymphocyte Response Against Htert.

Construction of an eukaryotic expression vector carrying amino acids 936-1132 of human telomerase reverse transcriptase and its expression in 293T cells

Construction of expression vector of hTERT/hIL-18 fusion gene in eukaryotic cells and its function]

[Construction of a General Piggybac Transposon Inducible Cell Immortalization Vector and Verification of Its Basic Properties].

Construction of retroviral vector expressing wild type p53 gene driven by hTERT promoter firstly by retrovirus only infecting dividing cells

[Construction of recombinant pEGFP/hTRT plasmid].

Expression of a Recombinant Vector of a Mutant Human Telomerase Reverse Transcriptase Gene in Human Bladder Cancer Cell Line T24, and Its Clinical Significance

CONSTRUCTION AND IDENTIFICATION OF hTERT cDNA RECOMBINANT ADENOVIRUS EXPRESSION VECTOR

Construction and Identification of Recombinant Adenovirus Vectors Expressing GFP and Human TERT-VEGF-Bcl-xl Short Hairpin RNA

Construction of Telomerase Shrna Lentivirus Vector and Transfection of Human Embryonic Stem Cells

[Construction of Tumor Cell-Specific Expression Vector Modulated by Human Telomerase Reserse Transcription Gene Core Promoter].

Construction and Identification of Mouse Telomerase Reverse Transcriptase Recombinant Adenovirus Vector